"Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway (vol 13, 791376, 2022)"
作者全名："Guo, Zhou; Lin, Jiamin; Sun, Kai; Guo, Jiayou; Yao, Xudong; Wang, Genchun; Hou, Liangcai; Xu, Jingting; Guo, Jiachao; Guo, Fengjing"
作者地址："[Guo, Zhou; Lin, Jiamin; Sun, Kai; Wang, Genchun; Hou, Liangcai; Xu, Jingting; Guo, Fengjing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Peoples R China; [Guo, Jiayou] Michigan State Univ, Broad Coll Business, E Lansing, MI USA; [Yao, Xudong] Chongqing Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Chongqing, Peoples R China; [Guo, Jiachao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat Surg, Wuhan, Peoples R China"
通信作者："Guo, FJ (通讯作者)，Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Orthoped, Wuhan, Peoples R China."
来源：FRONTIERS IN PHARMACOLOGY
ESI学科分类：PHARMACOLOGY & TOXICOLOGY
WOS号：WOS:000995290100001
JCR分区：Q1
影响因子：4.4
年份：2023
卷号：14
期号：
开始页：
结束页：
文献类型：Correction
关键词：osteoarthritis; chondrocytes; ferroptosis; deferoxamine; Nrf2
摘要：
基金机构：
基金资助正文：
